ABSTRACT
ObjectiveTo evaluate the dosage effect of measles， mumps and rubella combined attenuated live vaccine （MMR） vaccination on seroprevalence of mumps. MethodsA cross-sectional study was conducted among people in Changning District of Shanghai aged 1 month to 19 years old （n=1 816） in Mar.－Sep. 2017. Blood samples were analyzed for mumps antibodies using enzyme-linked immunosorbent immunoglobulin G （IgG） assays. ResultsMumps antibody seropositivity was 94.59% in 2 years old children and maintained at 98.18%-100.00% from 4 to 9 years old. The seropositivity began to decrease since 10 years， and it was 88.33% （95%CI： 81.20%-93.47%） at age of 12 years. In 12-19 years age group， individuals with 3 doses of mumps-containing vaccines had the highest seropositivity （93.88%） and individuals with 1 or 0 doses had the lowest seropositivity （68.75%）. ConclusionTwo-dose MMR immunization in Shanghai induces a sharp increase in mumps antibody levels in the corresponding age groups. The antibody levels decline gradually with time since the second dose. Vaccine dosage is positively associated with mumps IgG seropositivity and geometric mean concentrations （GMC） in 12-19 years old.
ABSTRACT
ObjectiveTo evaluate the dosage effect of measles， mumps and rubella combined attenuated live vaccine （MMR） vaccination on seroprevalence of mumps. MethodsA cross-sectional study was conducted among people in Changning District of Shanghai aged 1 month to 19 years old （n=1 816） in Mar.－Sep. 2017. Blood samples were analyzed for mumps antibodies using enzyme-linked immunosorbent immunoglobulin G （IgG） assays. ResultsMumps antibody seropositivity was 94.59% in 2 years old children and maintained at 98.18%-100.00% from 4 to 9 years old. The seropositivity began to decrease since 10 years， and it was 88.33% （95%CI： 81.20%-93.47%） at age of 12 years. In 12-19 years age group， individuals with 3 doses of mumps-containing vaccines had the highest seropositivity （93.88%） and individuals with 1 or 0 doses had the lowest seropositivity （68.75%）. ConclusionTwo-dose MMR immunization in Shanghai induces a sharp increase in mumps antibody levels in the corresponding age groups. The antibody levels decline gradually with time since the second dose. Vaccine dosage is positively associated with mumps IgG seropositivity and geometric mean concentrations （GMC） in 12-19 years old.
ABSTRACT
Penicillin-binding proteins (PBPs) are the target of β-lactam antibiotics (the major treatment for Streptococcus pneumoniae infections), and mutations in PBPs are considered as a primary mechanism for the development of β-lactam resistance in S. pneumoniae. This study was conducted to investigate the mutations in the PBPs of clinical S. pneumoniae isolates in Hangzhou, China, in correlation with β-lactam resistance. Results showed that 19F was the predominant serotype (7/27) and 14 of the S. pneumoniae isolates were resistant to both penicillin G and cephalosporin. Genotyping results suggested that β-lactam-resistant isolates primarily exhibited single-site mutations in both the STMK and SRNVP motifs of pbp1a in combination with double-site mutations in the STMK motif of pbp2x, which might be the primary mechanisms underlying the β-lactam resistance of the isolates in this study.
Subject(s)
Humans , Anti-Bacterial Agents , Pharmacology , China , Epidemiology , Drug Resistance, Bacterial , Pneumococcal Infections , Epidemiology , Microbiology , Streptococcus pneumoniae , Genetics , beta-Lactams , PharmacologyABSTRACT
Objective To analyze the changes of serum antibody levels of children in Changning District of Shanghai City, who received the second dose of varicella vaccine at one year after the first dose thereof.Methods A total of 206 children aged at 1 to 3 years in Changning District who had received one dose of varicella vaccine were included as objects of observation in the observation group.They received the second dose of varicella vaccine at one year after the first dose thereof.Their venous blood was collected before the second dose thereof as well as and at 35 to 42 days thereafter, and the varicella antibody level was tested through Fluorescent Antibody to Membrane Antigen(FAMA) assay so as to compare the difference between the antibody level before the second dose of varicella vaccine and that thereafter.Results The varicella-zoster virus(VZV) antibody titers of the blood serum before and after the second dose of varicella vaccine for the objects of observation were compared.The geometric mean titers(GMT) of the antibody before and after the second dose of varicella vaccine were 1∶11.90 and 1∶71.04, respectively, with the antibody level of the latter significantly higher than that of the former (t=18.1, P<0.01), which showed significant difference between the two.The objects of observation whose antibody levels increased to over 4 times their original antibody levels occupied 82.52% of the total objects of obervation.Conclusion The second dose of varicella vaccine received at one year after the first dose thereof can effectively improve the VZV antibody titer in the blood serum of immunization recipients.
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the significance in prevention of nosocomial infection of the testing of the associated contagious parameters of blood recipients before transfusion.</p><p><b>METHODS</b>A retrospective analysis was adopted, 44 968 pre-transfusion patients were tested the serum hepatitis B virus surface antigen (HBsAg), antibody against hepatitis C virus (anti-HCV), antibody against T. pallidum (anti-TP) and antibody against human immunodeficiency virus(anti-HIV).</p><p><b>RESULTS</b>The total positive rate was 22.41%. Positive rate of HBsAg, anti-HCV and anti-TP were 20. 67% (9294/44 968) , 0.33% (148/ 44 968) and 1.65% (9741/44968), respectively; anti-HIV was positive in 39 patients, 23 cases coinfection of the other three indicators at least one positive in 39 cases of anti-HIV-positive blood recipients, of which was mostly observed T. pallidum; co-infection of HBV, HCV and/or TP were 117 cases, and were mostly observed between HBV and HCV, HCV and TP; for HBV infection the department of digestive medicine was prevalent(Chi2>or=83.0, P <0.01).</p><p><b>CONCLUSION</b>Part of blood recipients before admission had been infected with a contagious disease. The testing of the associated contagious parameters of blood recipients before transfusion is not only useful for both of the hospital and the patients, but also more important to ensure safe blood transfusion, decrease medial dissatisfaction and to prevent nosocomial infection.</p>